ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2

<b>Background:</b> Vaccines represent one of the most affordable and efficient tools for controlling infectious diseases; however, the development of efficacious vaccines against complex pathogens remains a major challenge. Adjuvants play a relevant role in enhancing vaccine-induced immu...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan García-Arriaza, Michela Falqui, Patricia Pérez, Rocío Coloma, Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, David Astorgano, Irene Campaña-Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Carmen Elena Gómez, Susana Guerra
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Vaccines
Subjects:
ISG15
adjuvant
vaccines
MVA
ZIKV
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-393X/13/7/696
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items